Stockreport

GTG Launches Revolutionary geneType Test covering 100% Risk of Breast and Ovarian Cancer [Yahoo! Finance]

Genetic Technologies Ltd - American Depositary Shares  (GENE) 
US:NASDAQ Investor Relations: gtgcorporate.com/investor-centre
PDF is pleased to announce the Company has released its novel Comprehensive Risk Assessment test that covers 100% of women at risk of developing breast and ovarian cancer. [Read more]